Investigators enriched ubiquitinated proteins (UPs) from epirubicin (EPB)-induced multi-drug-resistant cancer stem-like breast cancer cell line and tested the efficacy of α-Al2O3-UPs-4T1/EPB as therapeutic vaccine alone and in combination with the stimulator of interferon genes (STING) agonist in mice with drug-resistant and metastatic breast cancer.
[Frontiers in Immunology]
7992332
{7992332:BBBBBBBB}
apa
50
1
166752
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/